Local
D.C. medical marijuana program ‘getting better’
Some say delays in patient approval encouraged street purchases

Although D.C. legalized the production and sale of marijuana for medical purposes just over 20 years ago, activists familiar with the city’s implementation of the program say it has become known for its long delays in approving patients for medical marijuana use.
People following the D.C. Department of Health’s operation of the city’s medical marijuana program say improvements were put in place in the past two months that appear to be streamlining a cumbersome bureaucratic process that they say discouraged many patients in need of medical marijuana.
Patricia Hawkins, a clinical psychologist and former deputy director of D.C.’s Whitman-Walker Health, said city delays in approving a patient’s application for a city approved medical card needed to allow the patient to buy medical marijuana at licensed dispensaries prompted some patients to resort to buying the marijuana from “pop-up” dealers who operate illegally, sometimes selling marijuana on the street.
“That’s the last thing we need them to do,” said Hawkins, who noted that the purity and content of marijuana bought on the black market is unknown and could have harmful additives such as pesticides.
She said street drug dealers also have the reputation for attempting to sell people other harmful drugs such as heroin.
Hawkins noted that LGBT and AIDS activists played an important role in persuading the city to enact the medical marijuana program in the late 1990s just prior to the availability of effective AIDS drugs. She said marijuana treatment was shown to be helpful to AIDS patients suffering from severe weight loss by increasing their appetite.
D.C.’s medical marijuana program is run by the Department of Health’s Division of Medical Marijuana and Integrative Therapy. Under rules established by the DOH, in order to become authorized to buy marijuana for medical purposes a patient must first obtain a written recommendation from his or her primary care physician.
“This recommendation must assert that the use of marijuana is medically necessary for the patient for the treatment of a qualifying medical condition or to mitigate the side effects of a qualifying medical treatment,” a statement on the DOH website says. The statement says the written recommendation must include the physician’s signature and license number.
The physician must then send that to the DOH. The patient is required to submit to the DOH a completed application form that shows proof of residency in D.C. and include a photo copy of a government issued identification document such as a driver’s license. A $100 registration fee is also required, with a $25 fee for a patient that qualifies for low-income status.
One D.C. patient who spoke to the Washington Blade about the process on condition that the patient not be identified said that in the recent past it took between two and four months for the DOH to process the patient’s application and send the needed medical card.
Under the city’s medical marijuana program, the medical card expires after one year and a new application must be submitted to have it renewed along with the $100 fee.
The patient that spoke to the Blade said only a few doctors in the city have the training or the desire to prescribe medical marijuana as a treatment for a medical condition.
“The waiting rooms are overfull and there’s a long time you have to wait to see the doctor,” said the patient.
“And then last year the Department of Health lost my paperwork so I had to go through the whole process again,” said the patient. “It’s just frustrating and annoying. And it’s way more cumbersome and way more bureaucratic than is necessary.”
Under changes made earlier this year, the DOH website now says applications for the medical card are processed within 30 business days.
Linda Green, owner of Anacostia Organics, one of six licensed medical marijuana dispensaries currently operating in the city, said the DOH last month began offering patients the option of submitting their application for the medical card online.
“The processing time has been cut down considerably,” she said. “The DOH says the process now can take just one week. They are saying it takes five to seven days to get your card,” added Green, who said she’s “very hopeful” that the streamlined process will encourage more patients in need of medical marijuana to enter the program.
The National Holistic Healing Center, another D.C. medical marijuana dispensary located near Dupont Circle, told the Blade in a statement there have been “considerable improvements to the process for obtaining a medical card.”
The statement, which doesn’t identify the person who wrote it, says National Holistic has patients who have received their medical card from the DOH in two to three weeks through the online application process.
Green of Anacostia Organics and the National Holistic statement said there are a wide range of different types of cannabis, the preferred name for marijuana by the dispensaries, from which a patient can choose to best meet their medical needs. Experts at the dispensaries will help the patient select the type best for them, some of which are inhaled, ingested, or absorbed through the skin.
DOH spokesperson Alison Reeves told the Blade in a statement the processing time for a medical marijuana card may vary from patient to patient. She said an incomplete patient application form can result in “increased processing time.”
She said the time of year a patient submits their application may also be a factor in the timing. She noted that the largest number of applications are submitted between February and April, with processing time possibly made longer during that peak period.
“It is our policy to process applications and issue cards within 30 business days, however processing time is normally much faster,” Reeves said. “For example, in the first quarter of this year the average processing time for completed applications was 8.5 business days – six days for electronic applications and 11 days for paper applications,” she said.
About nine months ago, according to Reeves, the DOH began accepting credit card payments.
“Originally, many banks would not allow this for any marijuana activities,” she told the Blade. “This change allowed patients to submit and pay online, which greatly decreased processing time.”
District of Columbia
Physician: addiction doesn’t always look the way you think it does
Yngvild Olsen headed HHS’s Center for Substance Abuse Treatment during Biden-Harris administration
Many people think the telltale signs of drug addiction include sweating and vomiting. But a prominent addiction medicine physician says the best signals aren’t always so visible.
Dr. Yngvild Olsen says more accurate signs come from the brain, specifically the compulsion to keep using drugs, including opioids, despite damage to education, career and relationships.
While it may be harder to understand the true nature of drug addiction, it’s never been more important because of the increased fatality risk of even microscopic amounts of fentanyl, which can be found in many illegal drugs.
Olsen, who headed the Center for Substance Abuse Treatment at the Department of Health and Human Services in the Biden-Harris administration, has worked in addiction treatment for more than two decades. She is now a healthcare advisor with the law and professional consulting firm Manatt, Phelps & Phillips and a physician at the Institute for Behavior Resources/Reach Health Services in Baltimore.
Olsen met with Youthcast Media Group to discuss her career, the opioid epidemic and what to know about fentanyl. The physician, a graduate of Harvard Medical School and the John Hopkins Bloomberg School of Public Health, cited her field experiences as key in shaping her perspective on addiction treatment and recovery. This interview is edited for clarity and length.
What made you believe this work in addiction treatment is important?
I had a couple of experiences really early on in my career that very significantly shaped my interest in addiction and addiction medicine, and my belief that I had a role, and that I could really help people get better from that disease. So the first was during the summer between my first and second year in medical school. I spent the summer on the Eagle Butte and Pine Ridge reservations in South Dakota and really saw firsthand just the devastating impact that substance use — in that case, alcohol — had on not only individuals, but their families and whole communities, and just how profound that impact had been for people who had lost their lives, who had lost family members, who had physically, emotionally and spiritually negative impacts of just feeling very hopeless and and trying to find solace in their substance use, particularly their alcohol use, and doing that without really finding it. I think that was really the lesson that experience taught me.
What did you learn about treatment practices during your medical education? How was that helpful to your career?
When I was a resident in general primary care at Boston Medical Center, I was really fortunate to have a group of mentors who also were general internists, like I was training to be, who were very interested and focused on medical education and research in substance use. And so they modeled for me many of the interactions that we had with patients. I got to do a research study with one of them looking at smoking cessation among people with opiate use disorder, taking methadone. And really importantly, I got to spend a month with one of them at the Boston City Public Health Department’s Opioid Treatment Program, or what some people call a methadone clinic, because he was their medical director. I got to see people recover, and who had recovered, who had gotten their lives back together, gotten their families back together, had new families (or) businesses. It was unbelievably helpful to see that people could recover, that they did recover, and that I, as a physician, could be part of their treatment. I saw people get better, and recover, with medications like methadone and buprenorphine, and other services designed individually for them. That was really helpful and kind of a big eye-opening moment for me.
What factors contribute to addiction and why is it considered a complex disease?
People come into treatment for their addiction — or when they’re not in treatment, but are in an emergency department or on the street — with a lot of shame. They have a lot of shame about this disease that they have, that for so long, they were told, ‘Well, you know, you should just stop. Why can’t you just stop?’ Well, we know that addiction is a disease. It’s a complex disease that has lots of different factors related to it. So there’s a big genetic component that combines with environmental factors and other risk factors. For example, people have what’s called adverse childhood experiences. Some of these are if they grow up with lots of physical or sexual abuse or emotional abuse or have parents who are in jail. That’s really traumatic and so all those childhood experiences that increase stress are a big risk factor.
What is the easiest opioid to get addicted to?
It used to be heroin. That was a big problem, particularly in the Northeast and other parts of the country. That shifted to prescription opioids, beginning around the year 2000. So for about 10 years, it was really prescription opioids that were a big problem — people misusing them. And then it switched back to heroin. And then in about 2015, fentanyl came on the scene, and that really changed the game, given just how unbelievably potent fentanyl is, so it doesn’t take a lot to cause an overdose. Now there are all those other synthetic opioids, like the orphines and nitazenes and all those combinations of other substances, but fentanyl is really what’s still kind of driving a really big part of the overdose crisis.
Do LGBTQ individuals face heightened challenges when battling addictions? How do addiction specialists like you account for those challenges?
We certainly know that the prevalence of overdose and the challenges of substances is higher in the LGBTQ+ community. Where I see patients, we did a big LGBTQ+ training and had a grant to specifically provide services to that population. Where we were located, in Baltimore City, there is a big transgender community not that far from us. Particularly in the LGBTQ+ population, they have multiple stigmas. So it just compounds multiple stressors. And stress is a risk factor for substance use, and particularly a risk factor for recurrence of a substance use disorder. And so when you have all these negative factors building up in people, that can make it that much more challenging for people to find the services that they find meaningful and that are welcoming and supportive of them. So we tried very hard — and we still do — to make sure that we are a welcoming and safe space, because I think it is that safety that is really paramount.
What advice would you give someone worried about a friend or family member’s substance use?
There are two things. One is: I would talk to that person about your concerns and how that person’s personality changes or their behavior changes when they’re using or in withdrawal, and how that might be impacting their health and how they’re feeling. And then second: you can let them know that there are actual treatments that are really helpful, that can make them feel better and that can help them get back to who they were before they started using. It’s important not to be accusatory because … [people] have a lot of shame already, and so when somebody starts accusing them, that shame just gets worse. And a lot of times, people who have a substance use disorder or are using opioids won’t necessarily agree that they have a problem when you first start to talk to them. But talk to them again every time something happens and say, ‘I’m really worried about you because this now has happened and I see it as being tied to your substance use.’ And let them know that there are people who can help and that they could actually feel a lot better.
This work is part of a partnership between the Washington Blade Foundation and Youthcast Media Group, funded in part through a FY26 Community Development Grant from the Office of D.C. Mayor Muriel Bowser. Adrian Malone is a senior at Bard High School Early College DC, one of Youthcast Media Group’s journalism class partners. Shreya Jyotishi, YMG assistant manager of content and programming, is a former Washington Blade intern and 2026 graduate of American University.
District of Columbia
Bet Mishpachah participates in D.C. Oct. 7 commemoration ceremony
Wednesday marked three years since Hamas attacked Israel
Bet Mishpachah Executive Director Joshua Maxey on Wednesday was among those who spoke at a ceremony in D.C. that marked the third anniversary of the Oct. 7 attack in Israel.
The Jewish Federation of Greater Washington hosted the ceremony that took place at the Washington Hebrew Congregation in Northwest D.C. Bet Mishpachah is the city’s LGBTQ synagogue.
“It was a deeply moving evening, especially hearing the stories of people who knew those who were murdered and those who survived and experiencing music that gave a voice to grief and hope,” Maxey told the Washington Blade.
Hamas militants on Oct. 7, 2023, killed roughly 1,200 people, including upwards of 360 partygoers at the Nova Music Festival near Re’im, a kibbutz that is a couple miles from the Gaza Strip, when it launched its surprise attack on Israel. The militants also kidnapped more than 200 people.
The Hamas-controlled Gaza Health Ministry says Israeli forces have killed more than 74,000 people in the enclave since Oct. 7.
The International Criminal Court in 2024 issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu; former Israeli Defense Minister Yoav Gallant; former Hamas leader Yahya Sinwar; Mohamed Diab Ibrahim al-Masri, the head of Hamas’s military wing known as the Qassam Brigades; and Ismail Haniyeh, chair of the Hamas Political Bureau, after it accused them of committing war crimes and crimes against humanity in Gaza and Israel.
The Israeli government has strongly denied it has committed genocide in Gaza.
An Israeli airstrike on a compound in Khan Younis, a city in southern Gaza, on July 13, 2024, killed killed Deif, one of the alleged Oct. 7 masterminds. Israel less than three weeks later assassinated Haniyah in Tehran, the Iranian capital. Israel Defense Forces soldiers on Oct. 16, 2024, killed Sinwar in Rafah, a city in southern Gaza.
Hamas last October released the remaining hostages in Gaza as part of a ceasefire agreement that President Donald Trump helped broker. Israel has continued to conduct airstrikes and other military operations in Gaza since the official suspension of hostilities took effect.
“For Bet Mishpachah, it was especially meaningful to lift up the names of LGBTQ+ people, those whose identities we know and those whose stories may never be fully known, who were murdered, and to honor the LGBTQ+ survivors whose resilience continues to inspire us,” said Maxey, referring to his participation in Wednesday’s ceremony. “Emily Damari’s story is particularly poignant: while held hostage, she had to hide the fact that she was gay because she feared that revealing her identity to her captors could put her life at even more risk. Yet, she survived.”
“Her story, like so many others, reminds us of the extraordinary courage it takes simply to remain human in the face of hatred,” he added. “May we continue to remember and to mourn, to honor, and to work toward a future rooted in peace and hope.”
Virginia
Campaign urges Virginia High School League to reverse stance on trans athletes
Equality Arlington and other advocacy groups behind ‘Right 2 Play’ VA’ initiative
Virginia advocacy groups have launched a campaign that urges the Virginia High School League to once again allow student athletes to compete on sports teams that correspond with their gender identity.
Equality Arlington on Sept. 16 published an article about the “Right 2 Play VA” campaign. Amy, a group representative, spoke about the initiative with the Washington Blade.
“The primary goal is to reverse the Virginia High School League’s discriminatory ban on allowing transgender girls to play on girls’ sports and replace it with a policy that is fair for all students.” they said.
The Virginia High School League in 2025 announced the policy, which reversed a previous position in support of transgender and nonbinary athletes. The 2025 policy coincided with President Donald Trump’s executive order — “Keeping Men Out of Women’s Sports” — that threatened to “rescind all funds from educational programs that deprive women and girls of fair athletic opportunities, which results in the endangerment, humiliation, and silencing of women and girls.”
The Arlington Gender Identity Alliance, Equality Virginia, and the American Civil Liberties Union of Virginia have also joined the “Right 2 Play VA” campaign.
“We had a policy in Virginia for 12 years that allowed transgender girls to play on girls’ sports teams, and we had not one instance — not one instance — that was brought forward demonstrating an unfair advantage or any type of safety concern,” said Amy.
Amy then discussed what they described are the benefits of trans youth playing sports.
“There are physical benefits. There are mental health benefits. There are community and social development benefits, and those are all well documented,” they said. “All kids should have the right to benefit from playing youth sports. We are talking about kids. We are talking about youth. We are not talking about Olympians. We are not talking about Division One college athletes. We are talking about kids in Virginia, and because the benefits of sports are so well documented, we think that every kid should have the ability to play sports.”
-
Photos5 days agoPHOTOS: Winchester Pride
-
Opinions5 days agoEvan Low is not the leader the Victory Fund needs at this moment
-
Brazil5 days agoTransgender woman elected to Brazilian Chamber of Deputies
-
District of Columbia5 days agoBowser, Office of LGBTQ Affairs announce LGBTQ+ History Month events
